| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970005 | The Journal of Heart and Lung Transplantation | 2015 | 8 Pages |
Abstract
De novo HLA antibodies are detectable post-transplant in the majority of patients, but non-DSA and transient DSA do not appear to be associated with poor outcomes. Patients with persistent DSA, especially those with Class II DQ antibodies, have worse survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Claire A. MRCPCH, MD, Vaughan PhD, FRCPath, Andrew R. MD, FRCPCH, Gareth MB, FRCP, Massimo FRCS, Asif FRCS, C. Richard MBBChir, FRCPCH,